Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615219-17-000082
Filing Date
2017-11-06
Accepted
2017-11-06 13:56:08
Documents
2
Period of Report
2017-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_150999455334207.html 3  
1 FORM 3 wf-form3_150999455334207.xml 3 4805
2 R. TUNG POWER OF ATTORNEY rtungpoaforsection16filings.htm EX-24 3290
  Complete submission text file 0001615219-17-000082.txt   9449
Mailing Address 99 HAYDEN AVENUE, SUITE 500 LEXINGTON MA 02421
Business Address
Tung Roger D (Reporting) CIK: 0001594857 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 171179070

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations